pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›recall
recall
save

Graviti Pharmaceuticals Private Limited recall (Cls II)

January 28, 2026updated 5mo ago
community read0 votes

Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10. — Reason: Presence of Foreign Substance — Status: Ongoing

view source ↗
Data sources
fda recalls
last refreshed 38m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

same company · ±60 days · 5

  • approvalAMLODIPINE BESYLATE — FDA approvalJan 26, 2026
  • approvalAMLODIPINE BESYLATE — FDA approvalFeb 17, 2026
  • approvalTRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalDec 29, 2025
  • approvalGLIPIZIDE — FDA approvalMar 4, 2026
  • approvalTRAMADOL HYDROCHLORIDE — FDA approvalDec 23, 2025

🐶 often sniffed alongside

top 8
  • tagRecall4 co-mentions · 2 sources
  • companyGraviti Pharmaceuticals Pvt Ltd2 co-mentions · 1 sources
  • drugAUVELITY2 co-mentions · 1 sources
  • drugFUROSEMIDE2 co-mentions · 1 sources
  • drugbupropion2 co-mentions · 1 sources
  • drugBUPROPION HYDROCHLORIDE2 co-mentions · 1 sources
  • drugbupropion hydrochloride ER2 co-mentions · 1 sources
  • drugbupropion hydrochloride MR2 co-mentions · 1 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?